Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 526

1.

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.

Tsakonas G, Botling J, Micke P, Rivard C, LaFleur L, Mattsson J, Boyle T, Hirsch FR, Ekman S.

Lung Cancer. 2019 Jul;133:69-74. doi: 10.1016/j.lungcan.2019.04.028. Epub 2019 May 1.

PMID:
31200831
2.

Long-term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease.

Sadeghi B, Remberger M, Gustafsson B, Winiarski J, Moretti G, Khoein B, Klingspor L, Westgren M, Mattsson J, Ringdén O.

Biol Blood Marrow Transplant. 2019 Jun 4. pii: S1083-8791(19)30359-3. doi: 10.1016/j.bbmt.2019.05.034. [Epub ahead of print]

PMID:
31173898
3.

Combination of the CIBMTR risk score and the global severity score enhances prognostic risk stratification in patients receiving frontline therapy for chronic GVHD.

Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH.

Biol Blood Marrow Transplant. 2019 Jun 3. pii: S1083-8791(19)30354-4. doi: 10.1016/j.bbmt.2019.05.029. [Epub ahead of print]

PMID:
31170520
4.

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis.

Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hägglund H, Mattsson J, Uhlin M.

Cent Eur J Immunol. 2019;44(1):84-91. doi: 10.5114/ceji.2018.75831. Epub 2019 Apr 15.

5.

BRAF status as a predictive factor for response in isolated limb perfusion.

Belgrano V, Mattsson J, Nilsson J, Olofsson Bagge R, Katsarelias D.

Int J Hyperthermia. 2019;36(1):511-515. doi: 10.1080/02656736.2019.1601778. Epub 2019 Apr 15.

PMID:
30987478
6.

Facing the future: challenges and opportunities in adoptive T cell therapy in cancer.

Magalhaes I, Carvalho-Queiroz C, Hartana CA, Kaiser A, Lukic A, Mints M, Nilsson O, Grönlund H, Mattsson J, Berglund S.

Expert Opin Biol Ther. 2019 Apr 30:1-17. doi: 10.1080/14712598.2019.1608179. [Epub ahead of print]

PMID:
30986360
7.

Leakage through the bone-marrow during isolated limb perfusion in the lower extremity.

Katsarelias D, Båth J, Carlson P, Mattsson J, Olofsson Bagge R.

J Surg Case Rep. 2019 Apr 3;2019(4):rjz090. doi: 10.1093/jscr/rjz090. eCollection 2019 Apr.

8.

A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease.

Csanadi M, Agh T, Tordai A, Webb T, Jeyakumaran D, Sengupta N, Schain F, Mattsson J.

Expert Rev Hematol. 2019 May;12(5):311-323. doi: 10.1080/17474086.2019.1605288. Epub 2019 Apr 19.

PMID:
30955381
9.

Programmed Cell Death Ligand 1 Immunohistochemistry: A Concordance Study Between Surgical Specimen, Biopsy, and Tissue Microarray.

Elfving H, Mattsson JSM, Lindskog C, Backman M, Menzel U, Micke P.

Clin Lung Cancer. 2019 Feb 27. pii: S1525-7304(19)30062-2. doi: 10.1016/j.cllc.2019.02.012. [Epub ahead of print]

PMID:
30926355
10.

Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status.

Agh T, Csanadi M, Voko Z, Webb T, Jeyakumaran D, Trudeau J, Sengupta N, Schain F, Mattsson J.

Expert Rev Hematol. 2019 May;12(5):295-309. doi: 10.1080/17474086.2019.1602036. Epub 2019 Apr 14.

PMID:
30925855
11.

Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.

La Fleur L, Falk-Sörqvist E, Smeds P, Berglund A, Sundström M, Mattsson JS, Brandén E, Koyi H, Isaksson J, Brunnström H, Nilsson M, Micke P, Moens L, Botling J.

Lung Cancer. 2019 Apr;130:50-58. doi: 10.1016/j.lungcan.2019.01.003. Epub 2019 Jan 9.

12.

The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.

Svenberg P, Wang T, Uhlin M, Watz E, Remberger M, Ringden O, Mattsson J, Uzunel M.

Clin Transplant. 2019 Mar 15:e13537. doi: 10.1111/ctr.13537. [Epub ahead of print]

PMID:
30873642
13.

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.

Rådestad E, Sundin M, Törlén J, Thunberg S, Önfelt B, Ljungman P, Watz E, Mattsson J, Uhlin M.

Front Immunol. 2019 Feb 11;10:189. doi: 10.3389/fimmu.2019.00189. eCollection 2019.

14.

Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan.

Nakajima A, Taniguchi S, Kurosu S, Gillberg PG, Mattsson JP, Camilleri M.

Neurogastroenterol Motil. 2019 May;31(5):e13571. doi: 10.1111/nmo.13571. Epub 2019 Feb 21.

PMID:
30793431
15.

T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation.

Gaballa A, Stikvoort A, Önfelt B, Mattsson J, Sundin M, Watz E, Uhlin M.

Bone Marrow Transplant. 2019 Feb 5. doi: 10.1038/s41409-019-0462-z. [Epub ahead of print]

PMID:
30723262
16.

Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.

Micke P, Botling J, Mattsson JSM, Planck M, Tran L, Vidarsdottir H, Nodin B, Jirström K, Brunnström H.

Sci Rep. 2019 Feb 4;9(1):1319. doi: 10.1038/s41598-018-37722-0.

17.

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Törlén J, Gaballa A, Remberger M, Mörk LM, Sundberg B, Mattsson J, Uhlin M.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1260-1268. doi: 10.1016/j.bbmt.2019.01.029. Epub 2019 Jan 30.

18.

Metabolic regulation of CAR T cell function by the hypoxic microenvironment in solid tumors.

Schurich A, Magalhaes I, Mattsson J.

Immunotherapy. 2019 Mar;11(4):335-345. doi: 10.2217/imt-2018-0141.

PMID:
30678555
19.

Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.

Edlund K, Madjar K, Mattsson JSM, Djureinovic D, Lindskog C, Brunnström H, Koyi H, Brandén E, Jirström K, Pontén F, Rahnenführer J, Micke P, Hengstler JG.

J Thorac Oncol. 2019 Apr;14(4):628-640. doi: 10.1016/j.jtho.2018.12.022. Epub 2019 Jan 9.

20.

Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma.

Belgrano V, Pettersson J, Nilsson JA, Mattsson J, Katsarelias D, Olofsson Bagge R.

Ann Surg Oncol. 2019 Apr;26(4):1055-1062. doi: 10.1245/s10434-018-07143-4. Epub 2019 Jan 7.

21.

Pre-formulation investigations for establishing a protocol for treosulfan handling and activation.

El-Serafi I, Loy O, Zhao Y, Oerther S, Mattsson J.

Pharm Dev Technol. 2019 Jun;24(5):639-648. doi: 10.1080/10837450.2018.1551903. Epub 2019 Jan 10.

PMID:
30474459
22.

Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review.

Fløisand Y, Lazarevic VL, Maertens J, Mattsson J, Shah NN, Zachée P, Taylor A, Akbari M, Quadri S, Parfionovas A, Chen YB.

Biol Blood Marrow Transplant. 2019 Apr;25(4):720-727. doi: 10.1016/j.bbmt.2018.11.013. Epub 2018 Nov 22.

23.

Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.

Djureinovic D, Dodig-Crnković T, Hellström C, Holgersson G, Bergqvist M, Mattsson JSM, Pontén F, Ståhle E, Schwenk JM, Micke P.

Lung Cancer. 2018 Nov;125:157-163. doi: 10.1016/j.lungcan.2018.09.012. Epub 2018 Sep 17.

PMID:
30429015
24.

Minimally invasive isolated limb perfusion - technical details and initial outcome of a new treatment method for limb malignancies.

Olofsson Bagge R, Carlson P, Razzazian R, Hansson C, Hjärpe A, Mattsson J, Katsarelias D.

Int J Hyperthermia. 2018;35(1):667-673. doi: 10.1080/02656736.2018.1522000. Epub 2018 Nov 14.

PMID:
30428725
25.

Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.

Belgrano V, Katsarelias D, Mattsson J, Olofsson Bagge R.

Eur J Surg Oncol. 2019 Feb;45(2):225-230. doi: 10.1016/j.ejso.2018.08.031. Epub 2018 Oct 19.

PMID:
30391091
26.

Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.

Vidarsdottir H, Tran L, Nodin B, Jirström K, Planck M, Jönsson P, Mattsson JSM, Botling J, Micke P, Brunnström H.

Hum Pathol. 2019 Feb;84:221-230. doi: 10.1016/j.humpath.2018.10.009. Epub 2018 Oct 31.

PMID:
30389437
27.

THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INHERITED DISEASES IS INFLUENCED BY HLA MATCH, YEAR OF TRANSPLANTATION AND IMMUNIZED FEMALE DONOR.

Ringden O, Remberger M, Gustafsson B, Moretti G, Mattsson J, Winiarski J, Sadeghi B.

Transplantation. 2018 Oct 8. doi: 10.1097/TP.0000000000002481. [Epub ahead of print]

PMID:
30300286
28.

Facilitating affective elements in learning - In a palliative care context.

Kangas-Niemi A, Manninen K, Mattsson J.

Nurse Educ Pract. 2018 Nov;33:148-153. doi: 10.1016/j.nepr.2018.09.007. Epub 2018 Oct 3.

PMID:
30296727
29.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

Ljungars A, Mårtensson L, Mattsson J, Kovacek M, Sundberg A, Tornberg UC, Jansson B, Persson N, Emruli VK, Ek S, Jerkeman M, Hansson M, Juliusson G, Ohlin M, Frendéus B, Teige I, Mattsson M.

NPJ Precis Oncol. 2018 Sep 3;2:18. doi: 10.1038/s41698-018-0061-2. eCollection 2018.

30.

Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.

Vidarsdottir H, Tran L, Nodin B, Jirström K, Planck M, Mattsson JSM, Botling J, Micke P, Jönsson P, Brunnström H.

Am J Clin Pathol. 2018 Oct 24;150(6):533-544. doi: 10.1093/ajcp/aqy083.

PMID:
30169783
31.

Operating Room Nurses' Perceptions of the Clinical Learning Environment: A Survey Study.

Crafoord MT, Mattsson J, Fagerdahl AM.

J Contin Educ Nurs. 2018 Sep 1;49(9):416-423. doi: 10.3928/00220124-20180813-07.

PMID:
30148539
32.

Nanoscale mechanics of microgel particles.

Aufderhorst-Roberts A, Baker D, Foster RJ, Cayre O, Mattsson J, Connell SD.

Nanoscale. 2018 Aug 30;10(34):16050-16061. doi: 10.1039/c8nr02911c.

PMID:
30106410
33.

An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.

Horie M, Miyashita N, Mattsson JSM, Mikami Y, Sandelin M, Brunnström H, Micke P, Nagase T, Saito A.

J Pathol. 2018 Oct;246(2):154-165. doi: 10.1002/path.5109. Epub 2018 Aug 13.

PMID:
29876935
34.

Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells.

Alnabhan R, Gaballa A, Mörk LM, Mattsson J, Uhlin M, Magalhaes I.

Cytotherapy. 2018 Jul;20(7):941-951. doi: 10.1016/j.jcyt.2018.04.007. Epub 2018 May 30.

PMID:
29859774
35.

The effect of N-acetyl-l-cysteine (NAC) on liver toxicity and clinical outcome after hematopoietic stem cell transplantation.

El-Serafi I, Remberger M, El-Serafi A, Benkessou F, Zheng W, Martell E, Ljungman P, Mattsson J, Hassan M.

Sci Rep. 2018 May 29;8(1):8293. doi: 10.1038/s41598-018-26033-z.

36.

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.

Nakajima A, Seki M, Taniguchi S, Ohta A, Gillberg PG, Mattsson JP, Camilleri M.

Lancet Gastroenterol Hepatol. 2018 Aug;3(8):537-547. doi: 10.1016/S2468-1253(18)30123-7. Epub 2018 May 25.

PMID:
29805116
37.

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Katsarelias D, Rådbo E, Ben-Shabat I, Mattsson J, Olofsson Bagge R.

Ann Surg Oncol. 2018 Jul;25(7):1836-1842. doi: 10.1245/s10434-018-6459-9. Epub 2018 May 15.

38.

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

La Fleur L, Boura VF, Alexeyenko A, Berglund A, Pontén V, Mattsson JSM, Djureinovic D, Persson J, Brunnström H, Isaksson J, Brandén E, Koyi H, Micke P, Karlsson MCI, Botling J.

Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31545. [Epub ahead of print]

39.

Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.

Pétursson HI, Kovács A, Mattsson J, Olofsson Bagge R.

PLoS One. 2018 Apr 12;13(4):e0195560. doi: 10.1371/journal.pone.0195560. eCollection 2018.

40.

Replik gällande granulocyttransfusion: - Rekommendationerna är väl underbyggda.

Berlin G, Cherif H, Knutson F, Mattsson J, Axdorph Nygell U.

Lakartidningen. 2018 Apr 6;115. pii: E6CC. Swedish. No abstract available.

PMID:
29634070
Free Article
41.

Granulocyte transfusion – when and how should it be used?

Berlin G, Cherif H, Knutson F, Mattsson J, Axdorph Nygell U.

Lakartidningen. 2018 Mar 20;115. pii: EXUU. Review. Swedish.

42.

Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.

Wang T, Remberger M, Axdorph Nygell U, Sundin M, Björklund A, Mattsson J, Uhlin M, Watz E.

Transfusion. 2018 Jun;58(6):1442-1451. doi: 10.1111/trf.14579. Epub 2018 Mar 13.

PMID:
29536557
43.

Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle.

Westerlund K, Altai M, Mitran B, Konijnenberg M, Oroujeni M, Atterby C, de Jong M, Orlova A, Mattsson J, Micke P, Karlström AE, Tolmachev V.

J Nucl Med. 2018 Jul;59(7):1092-1098. doi: 10.2967/jnumed.118.208348. Epub 2018 Feb 9.

PMID:
29439013
44.

Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysis.

Swartling L, Ljungman P, Remberger M, Sundin M, Tiveljung A, Mattsson J, Sparrelid E.

Transpl Infect Dis. 2018 Apr;20(2):e12847. doi: 10.1111/tid.12847. Epub 2018 Feb 26.

PMID:
29359843
45.

Diffusing-wave spectroscopy in a standard dynamic light scattering setup.

Fahimi Z, Aangenendt FJ, Voudouris P, Mattsson J, Wyss HM.

Phys Rev E. 2017 Dec;96(6-1):062611. doi: 10.1103/PhysRevE.96.062611. Epub 2017 Dec 18.

PMID:
29347446
46.

CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production Profile.

Magalhaes I, Kalland I, Kochenderfer JN, Österborg A, Uhlin M, Mattsson J.

J Immunother. 2018 Feb/Mar;41(2):73-83. doi: 10.1097/CJI.0000000000000193.

PMID:
29315094
47.

Risk Factors for Severe Acute Graft-versus-Host Disease in Donor Graft Composition.

Stikvoort A, Gaballa A, Solders M, Nederlof I, Önfelt B, Sundberg B, Remberger M, Sundin M, Mattsson J, Uhlin M.

Biol Blood Marrow Transplant. 2018 Mar;24(3):467-477. doi: 10.1016/j.bbmt.2017.11.026. Epub 2017 Nov 29.

48.

Migratory CD11b+ conventional dendritic cells induce T follicular helper cell-dependent antibody responses.

Krishnaswamy JK, Gowthaman U, Zhang B, Mattsson J, Szeponik L, Liu D, Wu R, White T, Calabro S, Xu L, Collet MA, Yurieva M, Alsén S, Fogelstrand P, Walter A, Heath WR, Mueller SN, Yrlid U, Williams A, Eisenbarth SC.

Sci Immunol. 2017 Dec 1;2(18). pii: eaam9169. doi: 10.1126/sciimmunol.aam9169.

PMID:
29196450
49.

Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

Ringdén O, Sadeghi B, Moretti G, Finnbogadottir S, Eriksson B, Mattsson J, Svahn BM, Remberger M.

Int J Hematol. 2018 Apr;107(4):478-485. doi: 10.1007/s12185-017-2363-5. Epub 2017 Nov 15.

PMID:
29143281
50.

COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer.

Gulyas M, Mattsson JSM, Lindgren A, Ek L, Lamberg Lundström K, Behndig A, Holmberg E, Micke P, Bergman B; Swedish Lung Cancer Study Group.

Acta Oncol. 2018 Feb;57(2):244-250. doi: 10.1080/0284186X.2017.1400685. Epub 2017 Nov 15.

PMID:
29140138

Supplemental Content

Loading ...
Support Center